Tyme Technologies, Inc. Underwriting AgreementTyme Technologies, Inc. • March 6th, 2018 • Pharmaceutical preparations • New York
Tyme Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom Evercore Group L.L.C., Stifel, Nicolaus & Company, Incorporated and Canaccord Genuity Inc. are acting as representatives (the “Representatives”), an aggregate of 9 million shares of Common Stock, par value $ 0.0001 per share, of the Company (the “Underwritten Shares”). The respective number of Underwritten Shares to be purchased by each Underwriter is set forth opposite its name in Schedule 1 hereto. In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 1,350,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are collectively referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
